Navigation Links
Data on Higher Dose of Copaxone and Data Showing Copaxone is Most,Cost Effective

ced by 75 percent (p<0.0001), compared to 65 percent in patients receiving the 20 mg dose (p<0.0001).


Relapse rates were also lower in patients who received the 40 mg dose of COPAXONE , when compared to those who received 20 mg dose (0.34 versus 0.57, respectively). Patients on 40 mg dose of COPAXONE experienced a reduced on-trial mean relapse rate of 77 percent when compared to the annual relapse rate prior to entry, versus patients who received the 20 mg dose (62 percent reduction). The time to the first relapse was significantly delayed from 80 days in the 20 mg group to 213 days in the 40 mg group (p = 0.0367). The overall safety profile was similar to that of the 20 mg dose. Some features of injection site reactions and immediate post-injection reactions were more common.


About Multiple Sclerosis


Multiple Sclerosis (MS) is the leading cause of neurological disability in young adults. It is estimated that 400,000 people in the United States are affected by this disease, and that over two million people are affected worldwide. MS is a progressive, demyelinating disease of the central nervous system affecting the brain, spinal cord and optic nerves.


Patients with MS may experience physical symptoms and/or cognitive impairments, including weakness, fatigue, ataxia, physical dysfunction, bladder and bowel problems, sensory effects, and visual impairment. MS also has a significant impact on the sufferers’ social functioning and overall quality of life.


About COPAXONE


COPAXONE is indicated for the reduction of the frequency of relapses in RRMS. The most common side effects of COPAXONE are redness, pain, swelling, itching, a lump or an indentation at the site of injection, weakness, infection, pain, nausea, joint pain, anxiety, and muscle stiffness.


COPAXONE is now approved in 47 countries worldwide, including the United States, Canada, Mexico, Australia, Israel
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
2. New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
3. Diabetes Linked to Higher Parkinsons Risk
4. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
5. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
6. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
7. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
8. First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
9. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
Post Your Comments:
(Date:7/7/2015)... , June 30, 2015 ... ) has announced the addition of the ... report to their offering. This ... biomedicine. Photoacoustic imaging is a safe, non-invasive, ... advantages and represents a great alternative to ...
(Date:7/7/2015)... VIEJO, Calif. , July 7, 2015 /PRNewswire/ ... company focused on developing innovative devices for the ... R. Michael Kleine has joined its Board ... over 25 years of medical device and healthcare ... biomedical companies where he has commercialized numerous leading-edge ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), ... the U.S. Food and Drug Administration (FDA) has approved ... and Mitigation Strategy) Access program. This new REMS is ... ABSTRAL ® (fentanyl) sublingual tablets, an ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. ... pharmaceutical company that specializes in patented biopharmaceutical ... and active pharmaceutical ingredients (API) today announced ... Chengdu Tianyin Pharmaceutical Co., Ltd,s ("Chengdu Tianyin") ...
Cached Medicine Technology:FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 2FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 3FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 4FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 5FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 6TPI Receives Approval for High Tech Enterprise Status 2
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri , ... treatments. A professional teeth whitening is one of the fastest, easiest ways to brighten ... they can decrease smile satisfaction and confidence. With the right teeth whitening treatment, patients ...
(Date:7/7/2015)... San Mateo, CA (PRWEB) , ... July 07, 2015 , ... ... and inspire others. California Casualty’s Nominate A Hero program offers a special ... Each month a well-deserving hero receives a $250 gift card and their place on ...
(Date:7/7/2015)... ... July 07, 2015 , ... Office ... the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins Office ... ranging from a multi-billion dollar, global chemical company to early and growth-stage technology ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... highly educated and motivated leaders with strong managerial expertise to oversee large ... communicate with patients, staff, providers, business partners, insurance companies, and regulators. American ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... management solutions, has announced the release of Service Pack 5600 for its ... a number of enhancements to the already robust capabilities of the reporting ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
... Maureen Salamon HealthDay Reporter , THURSDAY, Sept. 29 ... every corner of the globe, new research suggests that folks ... the workday progresses, regardless of where they live. The ... of 2.4 million people in 84 countries over two years, ...
... FRIDAY, Sept. 30 (HealthDay News) -- Unspoken clues -- ... according to a new study. Researchers from the University ... an impact on how patients view their relationship with ... The findings could help doctors better understand how they ...
... Franklin was right, at least on the healthy part. "Early to ... of early-bird Australian youths keep slimmer and more physically active than ... of sleep. A study in the Oct. 1 issue of ... of 2,200 Australian participants, ages 9 to 16, and compared their ...
... Picky eating is normal in children, but a pediatric feeding ... a child,s physical and mental development, an expert says. ... clinical director of the Pediatric Feeding Disorders Program at the ... reject certain foods but still has a nourishing diet. Children ...
... , THURSDAY, Sept. 29 (HealthDay News) --,New ... in a large-scale analysis of genetic data related to ... Philadelphia examined six large databases for DNA data from ... healthy people. In addition to validating results from ...
... LOS ANGELES (Sept. 29, 2011) Six leaders in ... will be key presenters at the world,s largest interdisciplinary ... The World Stem Cell Summit, co-sponsored by the ... the global stem cell and regenerative medicine community. ...
Cached Medicine News:Health News:Twitter Reflects World's Changing Moods 2Health News:Twitter Reflects World's Changing Moods 3Health News:Doctors Consider Nonverbal Cues in Medical Decisions 2Health News:Early to bed and early to rise -- study suggests it's keeping kids leaner 2Health News:Does Your Picky Eater Have a 'Feeding Disorder'? 2Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 2Health News:Cedars-Sinai scientists, physicians to be key presenters at World Stem Cell Summit 3
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
... uncuffed endotracheal tubes are available ... in standard or precut lengths., ... pediatric uncuffed endotracheal tubes are ... with a radiopaque blue line ...
... Line® uncuffed endotracheal tubes are ... styles, in standard or precut ... and pediatric uncuffed endotracheal tubes ... chloride with a radiopaque blue ...
Medicine Products: